# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-25-013137
Filing Date
2025-04-25
Accepted
2025-04-25 16:16:03
Documents
20
Period of Report
2025-06-10

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM DEF 14A | eton20250423_def14a.htm iXBRL | DEF 14A | 574198
6 |  | a01.jpg | GRAPHIC | 123999
7 |  | a02.jpg | GRAPHIC | 119632
8 |  | a03.jpg | GRAPHIC | 192461
9 |  | a04.jpg | GRAPHIC | 94189
10 |  | image01.jpg | GRAPHIC | 2465
| Complete submission text file | 0001437749-25-013137.txt |  | 2465526

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA | eton-20241231.xsd | EX-101.SCH | 4578
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | eton-20241231_def.xml | EX-101.DEF | 1750
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | eton-20241231_lab.xml | EX-101.LAB | 1775
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | eton-20241231_pre.xml | EX-101.PRE | 714
23 | EXTRACTED XBRL INSTANCE DOCUMENT | eton20250423_def14a_htm.xml | XML | 105590

Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

EIN.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38738 | Film No.: 25874274
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)